Adrenal function in children with severe asthma treatment with high-dose inhaled glucocorticoids: Recommended screening tests in outpatient conditions

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 7, 2007, Pages 781-789

  Breborowicz, Anna ^a   Niedziela, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adrenal gland; Asthma; Children; Inhaled glucocorticoids

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOTROPIN; CREATININE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; LEUKOTRIENE RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; PREDNISOLONE; THEOPHYLLINE;

ADOLESCENT; ADRENAL FUNCTION; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; CREATININE URINE LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HORMONAL REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LONG TERM CARE; LOW DRUG DOSE; MALE; METERED DOSE INHALER; NORMAL VALUE; OUTPATIENT; PATIENT COMPLIANCE; RECOMMENDED DRUG DOSE; SCREENING TEST; TREATMENT DURATION; URINALYSIS;

ADOLESCENT; ADRENAL CORTEX FUNCTION TESTS; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BLOOD GLUCOSE; BUDESONIDE; CHILD; FEMALE; HUMANS; HYDROCORTISONE; MALE;

EID: 34548240053     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Todd GR, Dunlop K, McNaboe, Ryan MF, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996; 348: 27-29.
2. Zimmerman B, Gold M, Wberrett D, Hanna A. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate. J Allergy Clin Immunol 1998; 101: 425-426.
3. Taylor AV, Laoprasert N, Zimmerman D, Sachs M. Adrenal suppression secondary to inhaled fluticasone propionate. Ann Allergy Asthma Immunol 1999; 83: 68-70.
4. Todd GR, Wright D, Ryan M. Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide. J Allergy Clin Immunol 1999; 103: 956-957.
5. Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85: 652-657.
6. Patel L, Wales JK, Kibirige MS, Massarano AA, Couriel JM, Clayton PE. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2002; 85: 330-334.
7. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461.
8. Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DR. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 2002; 19: 1207-1209.
9. Drake AJ, Howells RJ, Shield JPH, Prendiville A, Ward PS, Crowne EC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002; 324: 1081-1082.
10. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Resp J 2003; 21: 633-636.
11. Priftis KN, Papadimitriou A, Gatsopoulou E, Yiallouros PK, Fretzaya A, Nicolaidou P. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Resp J 2006; 27: 316-320.
12. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998; 157: S1-S53.
13. Passalacqua G, Albano M, Canonica GW, Bachert C, Van Cauwenberge P, Davies RJ, Durham SR. Kontou-Fili K, Horak F, Mailing HJ. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000; 55: 16-33.
14. Global Initiative for Asthma. Report NHLBI/WHO. NIH. NHLBI 2002. Publication No. 02-3569.
15. Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pneumonol 2002; 33: 208-220.
16. Sizonenko PC. Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth. J Pediatr Endocrinol Metab 2002; 15: 5-26.
17. Price J, Lenney W, Duncan C, Green L, Flood Y, Daley-Yates P, Barnacle H, Efthimiou J. HPA-axis efects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma. Respir Med 2002; 96: 625-631.
18. Jonetz-Mentzel L, Wiedemann G. Establishment of reference ranges for cortisol in neonates, infants, children and adolescents. Eur J Clin Chem Biochem 1993; 31: 525-529.
19. Walker JM, Hughes IA. Tests and normal values in paediatric endocrinology. In: Brook CJD, ed. Clinical Paediatric Endocrinology, 3rd Ed. Oxford: Blackwell Science, 1995; 789-790.
20. Reference values. In: Wilson JD, Poster DW, Kronenberg HM, Reed Larsen P, eds. Williams Textbook of Endocrinology, 9th Ed. Philadelphia, PA: W.B. Saunders Co., 1998.
21. Gomez MT, Malozowski S, Winterer J, Vamvakopoulos NC, Chrousos GP. Urinary free cortisol values in normal children and adolescents. J Pediatr 1991; 118: 256-258.
22. Pescollderungg L, Pietrobelli A, Boner AL. Adrenal insufficiency after treatment with fluticasone. Data on fluticasone are reassuring but what about doctors' prescribing? BMJ 2002; 325: 836.
23. Crowley S, Hindmarsh PC, Holownia P. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 1991; 130: 475-479.
24. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80: 1243-1246.
25. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of low dose (1 mcg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80: 1301-1305.
26. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44: 151-156.
27. Agwu T, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CGD. Tests of adrenal insufficiency. Arch Dis Child 1999; 80: 330-333.
28. Paton JY, Jardine E, McNeill E, Beaton S, Galloway P, Young D, Donaldson MD. Adrenal responses to low dose synthetic ACTh (synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child 2006; 91: 808-813.
29. Raux Demay MC, Magny JP, Idres N, Grimfeld A, Le Bouc Y. Use of the low-dose corticotropin stimulation test for the monitoring of children with asthma treated with inhaled corticosteroids. Horm Res 2006; 66: 51-60.
30. Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000; 356: 556-561.
31. Hindmarsh P. Exogenous glucocorticoids influence adrenal function, but assessment can be difficult. BMJ 2002; 324: 1083.
32. Yiallouros PK, Milner AD, Conway E, Honour JW. Adrenal function and high dose inhaled corticosteroids for asthma. Arch Dis Child 1997; 76: 405-410.
33. Crowley S. Inhaled glucocorticoids and adrenal function: an update. Paediatr Respir Rev 2003; 4: 153-161.
34. Allen DB. Inhaled steroids for children: effects on growth, bone, and adrenal function. Endocrinol Metab Clin N Am 2005; 34: 555-564.
35. Priftis KN, Papadimitriou A, Gatsopoulou E, Yiallouros PK, Fretzayas A, Nicolaidou P. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Respir J 2006; 27: 316-320.